Aehr Test Systems (NASDAQ:AEHR) Updates Q3 2024 Earnings Guidance

Aehr Test Systems (NASDAQ:AEHR) updated its third quarter 2024 earnings guidance on Monday. The company provided earnings per share guidance of -0.040–0.030 for the period, compared to the consensus earnings per share estimate of 0.130. The company issued revenue guidance of $7.6 million-$7.6 million, compared to the consensus revenue estimate of $14.3 million. Aehr Test Systems also updated its FY 2024 guidance to 0.480- EPS.

Aehr Test Systems Stock Up 11.5 %

AEHR opened at $12.46 on Thursday. Aehr Test Systems has a 52 week low of $10.53 and a 52 week high of $54.10. The firm has a 50-day simple moving average of $15.92 and a two-hundred day simple moving average of $25.51. The company has a market capitalization of $359.47 million, a PE ratio of 17.55 and a beta of 2.01.

Aehr Test Systems (NASDAQ:AEHR) last released its quarterly earnings results on Tuesday, January 9th. The semiconductor company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Aehr Test Systems had a net margin of 25.76% and a return on equity of 26.97%. The company had revenue of $21.43 million for the quarter, compared to the consensus estimate of $20.10 million. As a group, sell-side analysts expect that Aehr Test Systems will post 0.72 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. StockNews.com upgraded Aehr Test Systems from a sell rating to a hold rating in a research report on Friday, January 19th. William Blair reiterated a market perform rating on shares of Aehr Test Systems in a report on Monday. Finally, Craig Hallum reaffirmed a hold rating and issued a $12.00 price objective on shares of Aehr Test Systems in a research report on Tuesday.

Insiders Place Their Bets

In other news, CEO Gayn Erickson sold 4,871 shares of Aehr Test Systems stock in a transaction on Thursday, January 18th. The stock was sold at an average price of $17.39, for a total value of $84,706.69. Following the transaction, the chief executive officer now directly owns 427,935 shares in the company, valued at approximately $7,441,789.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, VP Avijit K. Ray-Chaudhuri bought 3,000 shares of the stock in a transaction on Friday, January 12th. The stock was bought at an average cost of $17.87 per share, for a total transaction of $53,610.00. Following the completion of the purchase, the vice president now directly owns 9,719 shares in the company, valued at $173,678.53. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gayn Erickson sold 4,871 shares of the stock in a transaction on Thursday, January 18th. The shares were sold at an average price of $17.39, for a total value of $84,706.69. Following the sale, the chief executive officer now owns 427,935 shares of the company’s stock, valued at approximately $7,441,789.65. The disclosure for this sale can be found here. Insiders have sold a total of 8,738 shares of company stock worth $151,723 in the last three months. Corporate insiders own 6.30% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in AEHR. Lazard Asset Management LLC purchased a new position in shares of Aehr Test Systems in the fourth quarter worth $34,000. Deutsche Bank AG purchased a new position in Aehr Test Systems in the 1st quarter worth $40,000. PNC Financial Services Group Inc. lifted its position in Aehr Test Systems by 93.0% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,158 shares of the semiconductor company’s stock worth $48,000 after acquiring an additional 558 shares during the period. Citigroup Inc. increased its holdings in shares of Aehr Test Systems by 463.8% in the fourth quarter. Citigroup Inc. now owns 2,458 shares of the semiconductor company’s stock valued at $49,000 after purchasing an additional 2,022 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in shares of Aehr Test Systems by 1,027.1% in the first quarter. JPMorgan Chase & Co. now owns 1,578 shares of the semiconductor company’s stock worth $49,000 after purchasing an additional 1,438 shares during the last quarter. 69.69% of the stock is currently owned by hedge funds and other institutional investors.

About Aehr Test Systems

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.